The results indicated that Keap1 mutations in Japanese individuals with NSCLC are not common, with observed frequencies demonstrated to be even lower compared with our previous in vitro analysis in lung cancer cell lines (50%) (11). This evidence concerns the gene KEAP1 and lung carcinoma.